Cargando…

Impact of Covid-19 on the treatment of acute myeloid leukemia

Detalles Bibliográficos
Autores principales:	Ferrara, Felicetto, Zappasodi, Patrizia, Roncoroni, Elisa, Borlenghi, Erika, Rossi, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304503/ https://www.ncbi.nlm.nih.gov/pubmed/32561842 http://dx.doi.org/10.1038/s41375-020-0925-7

Ejemplares similares

Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?
por: Ferrara, Felicetto
Publicado: (2020)

Current Therapeutic Results and Treatment Options for Older Patients with Relapsed Acute Myeloid Leukemia
por: Ferrara, Felicetto, et al.
Publicado: (2019)

Is There Still a Role for Autologous Stem Cell Transplantation for the Treatment of Acute Myeloid Leukemia?
por: Ferrara, Felicetto, et al.
Publicado: (2019)

PB1861: EFFICACY AND TOXICITY OF VENETOCLAX PLUS HYPOMETHYLATING AGENTS IN THE REAL LIFE OF ACUTE MYELOID LEUKEMIA
por: Martini, Gianluca, et al.
Publicado: (2023)

Pharmacokinetics of Venetoclax Co-Administered with Posaconazole in Patients with Acute Myeloid Leukemia
por: De Gregori, Simona, et al.
Publicado: (2023)

PB1823: THE BONE MARROW MICROENVIRONMENT IN ACUTE MYELOID LEUKEMIA: THE ROLE OF MESENCHYMAL STEM CELLS AND THEIR IMPACT ON THE CLINICAL OUTCOME
por: Calabretta, Ludovica, et al.
Publicado: (2023)

Diagnostic Workup of Acute Myeloid Leukemia: What Is Really Necessary? An Italian Survey
por: Voso, Maria Teresa, et al.
Publicado: (2022)

Orthodontic treatment for a patient with acute myeloid leukemia
por: Hsin-Chung Cheng, Johnson, et al.
Publicado: (2022)

The clinical impact of IKZF1 mutation in acute myeloid leukemia
por: Zhang, Xiang, et al.
Publicado: (2023)

Acute Myeloid Leukemia Masquerading as Acute Appendicitis
por: Shen, Kai, et al.
Publicado: (2017)

PB1858: PROGNOSIS AND TREATMENT OF FLT3 MUTATED MYELOID SARCOMA IN THE ERA OF FLT3 INHIBITORS: RETROSPECTIVE EVALUATION IN 5 ITALIAN CENTERS.
por: Lessi, Federica, et al.
Publicado: (2023)

Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey
por: Breccia, Massimo, et al.
Publicado: (2020)

Genomic landscape of hyperleukocytic acute myeloid leukemia
por: Largeaud, Laetitia, et al.
Publicado: (2022)

Integrative molecular subtypes of acute myeloid leukemia
por: Mo, Qianxing, et al.
Publicado: (2023)

Impact of blood count recovery on outcomes of acute myeloid leukemia patients achieving morphologic leukemia-free state
por: Cheng, Wen-Yan, et al.
Publicado: (2018)

Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome
por: Al-Kali, Aref, et al.
Publicado: (2023)

Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia
por: Jonas, Brian A., et al.
Publicado: (2022)

Enrichment of Double RUNX1 Mutations in Acute Leukemias of Ambiguous Lineage
por: Merati, Gabriele, et al.
Publicado: (2021)

Molecular predictors of post-transplant survival in acute myeloid leukemia
por: Qin, Tong, et al.
Publicado: (2017)

Plasmacytoid Dendritic Cells Proliferation Coexisted with Acute Myeloid Leukemia
por: Wang, Min, et al.
Publicado: (2018)

The immunometabolic landscape of the bone marrow microenvironment in acute myeloid leukemia
por: Xu, Binyan, et al.
Publicado: (2022)

The impact of lockdown during the COVID-19 pandemic on newly acute myeloid leukemia patients: Single-centre comparative study between 2019 and 2020 cohorts in Madrid
por: Martín-Moro, Fernando, et al.
Publicado: (2021)

Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
por: Tsai, Cheng-Hong, et al.
Publicado: (2017)

The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia
por: Qin, Ya-Zhen, et al.
Publicado: (2021)

Impact of emerging ACA on survival in chronic myeloid leukemia (CML)
por: Hehlmann, Rüdiger, et al.
Publicado: (2022)

Rare variants in Fanconi anemia genes are enriched in acute myeloid leukemia
por: Maung, Kyaw Ze Ya, et al.
Publicado: (2018)

B Cell Deficiency in Patients with Relapsed and Refractory Acute Myeloid Leukemia
por: Goswami, Meghali, et al.
Publicado: (2020)

Identification of a novel NPM1 mutation in acute myeloid leukemia
por: Yao, Yiyi, et al.
Publicado: (2023)

Characterizing the Molecular Abnormalities in Rare De Novo Ph(+) Acute Myeloid Leukemia
por: Chao, Hong-Ying, et al.
Publicado: (2018)

DLC1 deficiency at diagnosis predicts poor prognosis in acute myeloid leukemia
por: Li, Xueqian, et al.
Publicado: (2022)

Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia
por: Pitel, Beth A., et al.
Publicado: (2023)

Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant
por: Pabon, Cindy M., et al.
Publicado: (2021)

miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
por: Krakowsky, Rosanna H. E., et al.
Publicado: (2018)

Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants
por: Cicconi, Laura, et al.
Publicado: (2021)

Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults
por: Tsui, Sze P., et al.
Publicado: (2020)

Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy
por: Cairoli, Roberto, et al.
Publicado: (2023)

Use of CYP3Ai and impact on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine in the VIALE‐A study
por: Jonas, Brian A., et al.
Publicado: (2022)

A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia
por: Zheng, Hong, et al.
Publicado: (2020)

Signaling mechanisms that regulate ex vivo survival of human acute myeloid leukemia initiating cells
por: Bhavanasi, Dheeraj, et al.
Publicado: (2017)

The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
por: Moharram, Sausan A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cacugumdgu2931euddfvdqemlt